DALRIADA THERAPEUTICS
Dalriada is a small molecule drug discovery company supporting global innovators through its TURN-KEY model, where R&D is perfectly aligned with business and IP.
DALRIADA THERAPEUTICS
Industry:
Pharmaceutical
Founded:
2016-01-01
Address:
Mississauga, Ontario, Canada
Country:
Canada
Website Url:
http://www.dalriadatx.com
Total Employee:
11+
Status:
Active
Total Funding:
25 K USD
Technology used in webpage:
Euro Microsoft Exchange Online
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Delix Therapeutics
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Employees Featured
Founder
Investors List
University of Toronto
University of Toronto investment in Grant - Dalriada Therapeutics
UTEST
UTEST investment in Seed Round - Dalriada Therapeutics
FACIT
FACIT investment in Seed Round - Dalriada Therapeutics
More informations about "Dalriada Therapeutics"
Dalriada Drug Discovery - LinkedIn
Dalriada Drug Discovery | 10,843 followers on LinkedIn. Small Molecule Drug Discovery Services | Dalriada is a small molecule drug discovery company supporting global innovators through its …See details»
Dalriada - Vote for Charity Donation 2022
Dalriada - Vote for Charity Donation 2022See details»
Dalriada Therapeutics - Crunchbase Company Profile
Dalriada is a small molecule drug discovery company. View contacts for Dalriada Therapeutics to access new leads and connect with decision-makers.See details»
Dalriada brings in former Evotec executive Adam Davenport to …
May 3, 2023 Serving most recently as Head of Global Molecular Discovery at Evotec where he spent his whole career, Dr. Davenport is a seasoned drug discovery leader and innovator who …See details»
Dalriada Therapeutics - Overview, News & Similar companies
Jan 27, 2022 Dalriada brings in former Evotec executive Adam Davenport to lead strategy execution as Chief R&D Officer TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- Dalriada, …See details»
Dalriada brings in former Evotec executive Adam Davenport to …
May 3, 2023 Dr. Adam Davenport joins Dalriada Drug Discovery as Chief R&D Officer Dr. Adam Davenport joins Dalriada Drug Discovery as Chief R&D Officer TORONTO, May 03, 2023 …See details»
Dalriada brings in former Evotec executive Adam Davenport
TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces...See details»
Dalriada Drug Discovery Celebrates Client Dunad Therapeutics …
Nov 4, 2021 Dalriada is a leading Canadian contract research organization specialized in small molecule therapies. Purposely built as an agile, co-located and uniquely integrated drug …See details»
SYNTHETIC KETAMINE AND PSILOCYBIN / PSILICIN METABOLITE …
Jun 8, 2020 Dalriada, a leading contract research organization (CRO) in the drug discovery space, will lead Champignon’s new drug discovery programs in the NCE arena and further …See details»
About - Dalriada Drug Discovery
Founded in 2017, Dalriada is Ontario’s largest privately held contract research organization in small molecule therapies. The discovery path to PDC is complex and rarely linear. As a …See details»
Dalriada further strengthens small molecule discovery expertise …
Apr 19, 2023 Dr. Frosty Loechel Dr. Frosty Loechel joins Dalriada Drug Discovery as SVP Biology TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian …See details»
SilcsBio and Dalriada Drug Discovery Launch Partnership to Create …
FOR IMMEDIATE RELEASE: June 11, 2020, Baltimore, MD and Toronto, ON – SilcsBio, a technology company that develops innovative software and provides services for structure …See details»
Dalriada further strengthens small molecule discovery
TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies,...See details»
Careers - Dalriada Drug Discovery
Be at the forefront with Ontario’s largest and one of Canada’s fastest-growing drug discovery organizations. Our team of passionate and skilled drug discovery scientists is a key factor in …See details»
Dalriada Drug Discovery Celebrates Client Dunad Therapeutics …
Nov 4, 2021 Since its inception Dunad's R&D has been supported by Dalriada, a contract research organization to enable the development of their novel therapeutic modality that uses …See details»
Press Release - Dalriada Drug Discovery
Toronto, ON, April 19, 2023 – Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today the appointment of Frosty Loechel, …See details»
Dalriada Drug Discovery Signs New Agreement with Oxford …
Nov 23, 2021 Dalriada is a leading Canadian contract research organization specialized in small molecule therapies. Purposely built as an agile, co-located and uniquely integrated drug …See details»
Dalriada to Collaborate with atai New Platform Company to …
Toronto, ON, January 27, 2022 – Dalriada Drug Discovery (“Dalriada”) is pleased to announce a strategic collaboration with atai Life Sciences’ N.V. (Nasdaq: ATAI) newly launched platform …See details»
Dalriada Remains Operational During COVID-19: Series of Safety …
Apr 13, 2020 We hope that you and your families remain safe during these challenging times. As COVID-19 continues to spread and impact global activities, we would like to inform you that, …See details»